As TTFields are not tailored against any specific S protein amino acid sequence, but rather to the high protein polarity responsible for host receptor binding, they may be suitable for treatment of different COVID-19 variants, or possibly other types of viral infections, suggesting promise for this treatment option in the everchanging viral landscape. Here, PROS1 is linked to viral infectious disease.